Angiotensin-converting enzyme (ACE) is a glycosylated ectoprotein which is found in both cell-bound .and secreted forms. This enzyme is responsible for the synthesis of angiotensin II which has diverse physiological effects including maintenance of fluid and electrolyte balance and blood pressure. Elevated circulating levels of ACE are associated with the pathogenesis of 'essential' hypertension, heart failure, and renal failure and inhibitors of this enzyme are widely used for clinical management of these diseases. It is therefore important to understand the regulation of biosynthesis of ACE, its structure and its functions. In this application, we propose to use the powerful tools of molecular biology for this purpose. Previous investigations have shown that there are two isozymic forms of ACE, ACEp and ACET, which are expressed in a tissue specific manner. ACEp is synthesized in vascular endothelial cells and in the epithelial cells of kidney and intestine whereas ACET is synthesized only in sperm cells. Both isozymes originate from the same gene by alternative choice of two transcriptional start sites. The two resultant mRNAs, and the corresponding proteins, have common regions as well as isozyme-specific regions. We propose to investigate the molecular mechanisms responsible for tissue-specific expression of the two ACE mRNAs. For this purpose, we will study the cis-acting elements and trans-acting factors which regulate their transcription. The cis-acting elements will be identified by the expression of suitable chimeric reporter genes ,in transgenic mice and in transfected cells in culture. The trans-acting factors which bind to these cis-acting elements will be identified by electrophoretic mobility shift and footprinting assays. We also propose to ,study the routes of biosynthesis and secretion of the ACE proteins. Both permanent and transient transfectants will be used for this purpose. We will examine the effects of inhibiting glycosylation and cell-surface proteolytic activity on the synthesis, processing, and secretion of ACE. Using site-specific mutagenesis, we will identify the specific amino acid residues necessary for enzyme activity, membrane anchoring, and cleavage-processing of the protein. Finally, we will determine the enzymatic properties of cell-bound ACE by expressing a non-secretable form of ACE. The information obtained from the last aim ,will be valuable for understanding localized action of ACE in the body.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL048258-01
Application #
3367415
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1992-07-01
Project End
1997-06-30
Budget Start
1992-07-01
Budget End
1993-06-30
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Chattopadhyay, Saurabh; Kessler, Sean P; Colucci, Juliana Almada et al. (2014) Tissue-specific expression of transgenic secreted ACE in vasculature can restore normal kidney functions, but not blood pressure, of Ace-/- mice. PLoS One 9:e87484
Chattopadhyay, Saurabh; Karan, Goutam; Sen, Indira et al. (2008) A small region in the angiotensin-converting enzyme distal ectodomain is required for cleavage-secretion of the protein at the plasma membrane. Biochemistry 47:8335-41
Kessler, Sean P; Senanayake, Preenie deS; Gaughan, Christina et al. (2007) Vascular expression of germinal ACE fails to maintain normal blood pressure in ACE-/- mice. FASEB J 21:156-66
Chattopadhyay, Saurabh; Santhamma, Kizhakkekara R; Sengupta, Saubhik et al. (2005) Calmodulin binds to the cytoplasmic domain of angiotensin-converting enzyme and regulates its phosphorylation and cleavage secretion. J Biol Chem 280:33847-55
Kessler, Sean P; Hashimoto, Seiji; Senanayake, Preenie S et al. (2005) Nephron function in transgenic mice with selective vascular or tubular expression of Angiotensin-converting enzyme. J Am Soc Nephrol 16:3535-42
Kessler, Sean P; deS Senanayake, Preenie; Scheidemantel, Thomas S et al. (2003) Maintenance of normal blood pressure and renal functions are independent effects of angiotensin-converting enzyme. J Biol Chem 278:21105-12
Kessler, Sean P; Gomos, Janette B; Scheidemantel, Thomas S et al. (2002) The germinal isozyme of angiotensin-converting enzyme can substitute for the somatic isozyme in maintaining normal renal structure and functions. J Biol Chem 277:4271-6
Kessler, S P; Rowe, T M; Gomos, J B et al. (2000) Physiological non-equivalence of the two isoforms of angiotensin-converting enzyme. J Biol Chem 275:26259-64
Sadhukhan, R; Sen, G C; Ramchandran, R et al. (1998) The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface. Proc Natl Acad Sci U S A 95:138-43
Ramaraj, P; Kessler, S P; Colmenares, C et al. (1998) Selective restoration of male fertility in mice lacking angiotensin-converting enzymes by sperm-specific expression of the testicular isozyme. J Clin Invest 102:371-8

Showing the most recent 10 out of 23 publications